Search
for

    Glossary SM04554

    investigational drug studied for treating androgenetic alopecia

    SM04554 is an investigational drug being studied for its potential to treat androgenetic alopecia, a common form of hair loss. It is believed to work by modulating the Wnt signaling pathway, which plays a crucial role in hair follicle development and growth.

    Research 10 of 43

    1. Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial Journal of The American Academy of Dermatology · 2016 · 2 citations
    2. Safety and biopsy outcomes of a topical treatment (SM04554) for male androgenetic alopecia (AGA): Results from a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial Journal of The American Academy of Dermatology · 2017 · 1 citations
    3. 712 A small molecule modulator of the wnt pathway (SM04554) as a potential topical treatment for androgenetic alopecia (AGA) Journal of Investigative Dermatology · 2017 · 1 citations
    4. WNT Signaling in Disease Cells · 2019 · 144 citations
    5. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    6. Biotechs target stagnant baldness market Nature Biotechnology · 2016 · 3 citations
    7. Randomized controlled evaluator blinded study of dutasteride versus finasteride in men with androgenetic alopecia Journal of The American Academy of Dermatology · 2016 · 1 citations
    8. New Drugs for Alopecias 2019
    9. Safety and efficacy of a novel skin lightening agent for melasma Journal of The American Academy of Dermatology · 2017
    10. Safety and compatibility of a new nourishing baby shampoo and tip to toe wash with stearic acid Journal of The American Academy of Dermatology · 2017
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →